BenevolentAI harnesses artificial intelligence to enhance and accelerate scientific discovery by making sense of highly fragmented information to create new insights and usable knowledge that benefit society.
Since our foundation in 2013, our mission has been to bring the power of humans and machines together to make sense of, and drive rapid scientific discovery.
We saw the opportunity to forge a powerful union between humans, technology and bioscience using AI. The purpose of this was to accelerate global scientific discovery by turning the world’s highly fragmented scientific information into new insight and usable knowledge that ultimately benefits society.
Our unique proprietary AI technology, the Judgement Augmented Cognition System (JACS), is at the core of everything we do. JACS uses cutting edge deep learning techniques to change the way knowledge is created, connected and applied and enables the mass analysis of vast amounts of scientific information. This provides experienced scientists with the augmented insight and analytical tools they need to use previously impenetrable complex and deep knowledge to dramatically speed up scientific discovery.
In September 2016, BenevolentAI created two distinct business units; ‘BenevolentBio’ which applies BenevolentAI’s technology in human health and the exploration of further bioscience applications, and, ‘BenevolentTech’ which refines and develops the company’s technology and replicates our initial success across wider applications and industries. These two companies work together symbiotically, creating a virtuous circle of AI development and drive our overall purpose – a technology company specialising in the application of AI for a broad range of benevolent uses.
Latest funding size
Time since last funding
|over 1 year|
|Lundbeck, Woodford Investment Management, Lansdowne Partners, Upsher Smith Laboratories|